What the ADA 2025 trial data reported, and the accessible analog
Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
When combined with diet and exercise, patients often report increased energy and improved weight-loss results
The experts and experienced clinicians at InVita Wellness will take every measure to ensure your comfort, safety and satisfaction
Nursing Mothers: Vitamin B12 is known to be excreted in human milk
Highly recommend this practice